This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Severe trauma (severe trauma, ISS ≥15) — integrated care centered on regional trauma centers (Severe trauma with Injury Severity Score of 15 or higher — injury assessment, ATLS, damage control surgery, massive transfusion) (Severe Trauma ISS≥15 — Regional Trauma Center-Based Integrated Care)

ICD-10: regional trauma center admission code  |  Special Copayment Reduction: V273 (Special Copayment Reduction for severe trauma: ISS ≥15, admission to a regional trauma center, 5% copayment for up to 30 days from the registration date)

S1. ISS injury severity scoring system and V273 Special Copayment Reduction

The Injury Severity Score (ISS) is an anatomical severity scoring system proposed by Baker and colleagues in 1974 that has become the standard in trauma research and clinical practice worldwide. The ISS divides the body into 6 regions (① head and neck, ② face, ③ chest, ④ abdominal and pelvic organs, ⑤ extremities and pelvic skeleton, ⑥ skin and external) and is calculated by summing the squares of the highest Abbreviated Injury Scale (AIS) grades of 3 regions. The ISS ranges from 1 to 75, and ISS ≥15 is widely used as the criterion for severe trauma.

ISS = sum of AIS² for each of the three regions with the highest AIS

AIS grades: 1=minor, 2=moderate, 3=serious (not life-threatening), 4=severe (life-threatening), 5=critical (survival uncertain), 6=unsurvivable. If any region has AIS 6, the ISS is automatically 75.

New Injury Severity Score (NISS): sums the squares of the 3 highest AIS scores regardless of region, reflecting multiple injuries in the same region more accurately than the ISS. NISS is also used alongside ISS in Korean trauma research.

V273 Special Copayment Reduction: the Special Copayment Reduction for severe trauma, under which a 5% copayment applies for up to 30 days from the registration date when a patient with ISS ≥15 is admitted to a regional trauma center. Implemented together with the introduction of the regional trauma center system in Korea in 2012, it has the policy purpose of reducing the financial burden on patients with severe trauma and encouraging concentrated treatment at regional trauma centers.

V273 registration requirements: ① ISS ≥15 (recorded in the trauma registry system); ② admission to a regional trauma center (emergency admission or admission via the emergency department); ③ applies for up to 30 days (unlike general Special Copayment Reduction, there is a time limit). If the same admission continues beyond 30 days, it is converted to general National Health Insurance coverage.

S2. Epidemiology of severe trauma — status of regional trauma centers in Korea

Trauma is the leading cause of death worldwide in people under 45. In Korea, trauma is also a major cause of death, with about 10,000–12,000 people dying of trauma each year, of whom about 30–40% are estimated to be preventable deaths had there been appropriate medical access and treatment.

Korea's regional trauma center system began with the first designation of regional trauma centers in 2012, and 17 centers are currently in operation nationwide. Core requirements of a regional trauma center: ① trauma surgery specialists on site 24 hours; ② operation of dedicated trauma operating rooms and intensive care units; ③ linkage with a specialized helicopter transport system; ④ a severe trauma team (composed of specialists in trauma surgery, neurosurgery, thoracic surgery, orthopedics, anesthesiology, critical care medicine, and emergency medicine). By transporting minor trauma to local emergency departments and concentrating severe trauma with ISS ≥15 at regional trauma centers, the system aims to improve resource efficiency and treatment outcomes.

Korean trauma statistics (National Emergency Medical Center, 2023): about 5–8% of patients visiting emergency departments due to trauma are classified as severe trauma (ISS ≥15). Traffic accidents are the most common at about 40–50%, followed by falls at 30–40% and assault at 5–10%. With concentrated treatment of severe trauma patients at regional trauma centers, the preventable death rate is reported to have decreased from 35–40% before introduction to 20–25% after introduction.

S3. ATLS systematic initial assessment — Primary and Secondary Survey

The ATLS (Advanced Trauma Life Support) system is the standard for initial trauma care developed by the American College of Surgeons in 1978 and is used in more than 80 countries worldwide. ATLS training is also mandatory in Korea, and it is the basic treatment protocol of regional trauma centers.

Primary Survey (ABCDE):

Secondary Survey: systematic head-to-toe evaluation of the whole body while the Primary Survey and resuscitation are under way. Identify injuries by region and perform additional imaging (FAST, CT) as needed.

S4. Trauma resuscitation — hemorrhage control and fluid strategy

40% of severe trauma deaths are due to hemorrhage. The paradigm of trauma resuscitation has changed greatly since the 2000s, shifting from administration of large volumes of crystalloid to balanced transfusion centered on blood products.

Permissive hypotension: when active bleeding continues, giving excessive fluids to normalize blood pressure dislodges clots and worsens dilutional coagulopathy. Permissive hypotensive resuscitation, maintaining a target systolic blood pressure (SBP) of 80~90 mmHg until surgical hemorrhage control, improves survival. However, when head trauma is present, the target is SBP ≥90 mmHg (or MAP ≥70 mmHg) to maintain cerebral perfusion pressure.

Hemostatic agents:

S5. Massive transfusion protocol (MTP)

Massive transfusion is defined as transfusion of 10 or more units of packed red blood cells (pRBC) within 24 hours. The trauma Massive Transfusion Protocol (MTP) is a balanced transfusion strategy that administers blood products in a 1:1:1 ratio (pRBC:FFP:platelets) to prevent coagulation factor deficiency and dilutional coagulopathy.

MTP activation criteria (ABC Score, Assessment of Blood Consumption):

ItemPositive criterionScore
Penetrating mechanism of injuryYes1
ED SBP≤90 mmHg1
ED HR≥120 bpm1
FAST positiveFree intra-abdominal fluid1

ABC score ≥2: MTP activation. Sensitivity 75%, specificity 86%.

MTP transfusion ratio: pRBC : FFP : platelets = 1 : 1 : 1. In the PROPPR randomized controlled trial (2015), the 1:1:1 ratio significantly improved 24-hour survival compared with the 1:1:2 ratio.

Viscoelastic testing: real-time monitoring of coagulation status using thromboelastography (TEG) or rotational thromboelastometry (ROTEM) allows tailored administration of blood products. Goal-directed transfusion based on TEG/ROTEM is being introduced at some regional trauma centers in Korea.

Lethal triad of trauma: three mutually aggravating factors: hypothermia (<35°C) + acidosis (pH <7.2) + coagulopathy. Breaking this triad is the key goal of trauma resuscitation. Maintenance of body temperature, correction of metabolic acidosis (transfusion and lactate monitoring), and early replacement of coagulation factors are pursued simultaneously.

S6. Damage control resuscitation (DCR) and damage control surgery (DCS)

Damage control resuscitation (DCR) and damage control surgery (DCS) are a staged strategy in physiologically unstable severe trauma patients in which, instead of immediate complete surgery, only life-threatening injuries are minimally controlled, resuscitation is continued in the intensive care unit, and definitive surgery is then performed secondarily.

Components of DCR:

3 stages of DCS:

  1. Stage 1 (DCS I — Control): hemorrhage control (packing, vessel ligation or shunt insertion) and contamination control (ligation or temporary closure of bowel injuries) in the emergency operating room. The goal is an operative time of <90 minutes. For the abdomen, temporary abdominal closure (TAC): negative pressure wound therapy (NPWT) or a Bogota bag is used.
  2. Stage 2 (DCS II — ICU Resuscitation): normalization of physiological parameters in the trauma intensive care unit. The goals are normalization of body temperature (>36°C), pH >7.35, lactate <2 mmol/L, and normalization of calcium, platelets, and coagulation factors.
  3. Stage 3 (DCS III — Definitive): definitive surgery after physiological stabilization (24~72 hours). Reopening of the abdomen, repair of remaining injuries, bowel anastomosis, abdominal wall reconstruction.

Endovascular hemostasis in vascular injury (REBOA: Resuscitative Endovascular Balloon Occlusion of the Aorta): aortic balloon occlusion temporarily controls bleeding below it and maintains cardiac and cerebral blood flow. REBOA has been introduced at some regional trauma centers in Korea and is used for pelvic hemorrhage and massive intra-abdominal hemorrhage.

S7. Head trauma — management of severe TBI

Severe head trauma (severe TBI: Traumatic Brain Injury) is defined as GCS ≤8 and is one of the most common causes of death in severe trauma. Minimizing secondary brain injury in trauma patients is key to neurological prognosis.

Causative factors of secondary brain injury:

Initial management of severe TBI (based on the BTF 2016 guidelines):

Acute epidural hematoma: immediate surgery if thickness >15 mm, volume >30 mL, or neurological abnormality. Acute subdural hematoma: immediate surgery if GCS declines or hematoma on CT >10 mm, thickness >5 mm or more.

S8. Chest trauma — hemothorax, pneumothorax, cardiac injury

Chest trauma occurs in about 60% of severe trauma patients, and 25% of trauma deaths are directly attributable to chest injury. Most (85%) chest injuries can be treated with chest tube insertion alone, and surgery is needed in less than 15%.

Hemothorax: bleeding into the pleural cavity. Massive hemothorax of 1 liter or more, or continued bleeding of 200 mL or more per hour after drainage, is an indication for surgery. A chest tube (32Fr or larger) is inserted at the 5th intercostal space in the midaxillary line to achieve drainage and lung re-expansion simultaneously.

Pneumothorax: tension pneumothorax is an emergency requiring immediate needle decompression followed by chest tube insertion. In open chest injury, a 3-sided seal blocks air entry while maintaining negative intrapleural pressure. For pneumothorax found on chest X-ray and ultrasound, chest tube insertion is the rule when mechanical ventilation is planned.

Cardiac contusion and cardiac tamponade: cardiac contusion is diagnosed after high-energy chest trauma by arrhythmia, wall motion abnormalities, and elevated cardiac enzymes. Cardiac tamponade (Beck's triad: hypotension, elevated venous pressure, muffled heart sounds) is diagnosed by FAST and treated by pericardiocentesis or immediate surgery. For traumatic aortic injury, when hemodynamically stable, endovascular stent graft (TEVAR) treatment is preferred after confirmation by contrast chest CT.

S9. Abdominal trauma — non-operative management and surgical indications

In the initial assessment of abdominal trauma, FAST (Focused Assessment with Sonography for Trauma) is the key tool for rapidly identifying free intra-abdominal fluid. Hemodynamically unstable FAST-positive patients should, as a rule, undergo immediate surgery (emergency laparotomy).

Non-operative management (NOM): for hemodynamically stable intra-abdominal injuries (spleen, liver, kidney), non-operative management has become established as standard treatment. Criteria for NOM success: hemodynamic stability, no active intra-abdominal bleeding (no contrast extravasation on contrast CT), no signs of peritoneal irritation, and a conscious patient who can be followed. If NOM fails (drop in blood pressure, worsening peritoneal irritation), convert immediately to surgery.

Angioembolization: for bleeding from hepatic, splenic, or pelvic vessels, endovascular embolization is performed as an interventional radiology procedure. In severe splenic injury (AAST Grade IV-V), combining non-operative management with embolization has improved the success rate of splenic preservation.

Surgical indications: hemodynamic instability + FAST positive (immediate surgery), signs of peritoneal irritation, pneumoperitoneum (suspected bowel perforation), NOM failure, diaphragmatic injury, vascular injury (hemodynamic instability). Surgical approach: for bowel injury, the DCS concept is applied, with temporary ligation followed by anastomosis at the second operation.

S10. Musculoskeletal trauma — pelvic fractures and limb fractures

Pelvic fractures and limb fractures commonly accompany severe trauma and are major causes of massive bleeding and functional impairment.

Pelvic ring fracture — massive hemorrhage: in unstable pelvic fractures (Tile type C: simultaneous disruption of anterior and posterior structures), up to 3~5 liters of bleeding occurs within the pelvis. Initial management: ① immediate application of a pelvic binder or T-POD — tamponade effect by reducing pelvic volume; ② continued resuscitation; ③ confirmation of vascular injury by contrast CT; ④ pelvic angioembolization — effective for venous or small arterial bleeding; ⑤ pelvic packing — control of venous bleeding by preperitoneal packing. Definitive surgery: external fixation or internal fixation is performed after the patient's condition stabilizes.

Damage control orthopedics (DCO) for limb fractures: in unstable severe trauma patients, immediate definitive surgery of limb fractures worsens the systemic inflammatory response through a "second hit" effect. DCO principle: stabilize fractures with immediate external fixation, then convert to internal fixation after physiological stabilization and improvement in general condition (days to weeks).

Amputation: emergency amputation may be needed for a mangled limb, unsalvageable vascular injury, or control of fatal hemorrhage. In modern trauma surgery, limb salvage is attempted as far as possible, and the decision to amputate follows strict criteria (MESS score ≥7: Mangled Extremity Severity Score).

S11. Trauma intensive care unit management — prevention of complications

In trauma ICU management of severe trauma survivors, prevention of secondary organ damage and management of complications are key.

Major complications in the trauma ICU:

Nutritional support: early enteral nutrition (within 24~48 hours) is effective in severe trauma patients for protecting the intestinal mucosa and reducing infectious complications. Target protein 1.5~2.0 g/kg/day. If gastric residual volume (GRV) >200 mL, consider small bowel feeding. Hyperglycemic complications are prevented with intensive insulin therapy (target blood glucose 140~180 mg/dL).

S12. Prognosis and rehabilitation — multidisciplinary approach

The prognosis of patients with severe trauma (ISS ≥15) varies greatly with injury type, severity, age, comorbidities, and speed of treatment initiation. Concentrated treatment at regional trauma centers has improved overall mortality, but long-term functional impairment and reduced quality of life in survivors remain important challenges.

Prognostic tools:

Post-trauma rehabilitation: rehabilitation of severe trauma survivors begins immediately after the acute phase and continues over a long period. Early mobilization prevents muscle wasting and ICU-acquired weakness. Rehabilitation team: physical medicine and rehabilitation, physical therapists, occupational therapists, speech therapists (for swallowing and voice problems), clinical psychologists (treatment of PTSD and depression), social workers (disability assessment, support for social reintegration).

Post-traumatic stress disorder (PTSD): PTSD develops in about 10~30% of severe trauma survivors. Early psychological screening (PCL-5) and cognitive behavioral therapy (CBT) or EMDR (eye movement desensitization and reprocessing) are effective. Continued rehabilitation and psychological support are needed even after the V273 Special Copayment Reduction ends, and for those with severe disability, linkage to disability welfare services is provided.

S13. References

  1. Baker SP, O'Neill B, Haddon W Jr, Long WB. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187-196. PMID: 4814394.
  2. American College of Surgeons. ATLS: Advanced Trauma Life Support Student Manual, 10th Edition. Chicago: American College of Surgeons; 2018.
  3. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32. doi:10.1016/S0140-6736(10)60835-5. PMID: 20554319.
  4. Holcomb JB, Tilley BC, Baraniuk S, et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471-482. doi:10.1001/jama.2015.12. PMID: 25647203.
  5. Tien HC, Spencer F, Tremblay LN, Rizoli SB, Brenneman FD. Preventable deaths from hemorrhage at a level I Canadian trauma center. J Trauma. 2007;62(1):142-146. doi:10.1097/TA.0b013e31802d8d8d. PMID: 17215745.
  6. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury, 4th edition. Neurosurgery. 2016;80(1):6-15. doi:10.1227/NEU.0000000000001432. PMID: 28005361.
  7. Balogh ZJ, Reumann MK, Gruen RL, et al. Advances and future directions for management of trauma patients with musculoskeletal injuries. Lancet. 2012;380(9847):1109-1119. doi:10.1016/S0140-6736(12)60991-X. PMID: 23021249.
  8. Duchesne JC, McSwain NE Jr, Cotton BA, et al. Damage control resuscitation: the new face of damage control. J Trauma. 2010;69(4):976-990. doi:10.1097/TA.0b013e3181f2abc9. PMID: 20938266.
  9. Kim OH, Kim YH, Kim HI, et al. Outcome and factors affecting preventable death in major trauma patients: a single regional trauma center study. Emerg Med J. 2016;33(1):23-29. doi:10.1136/emermed-2014-204361. PMID: 26142191.
  10. Jung KY. Current status of trauma systems in Korea: Establishment of a trauma system and outcomes over the past decade. J Korean Med Sci. 2020;35(29):e250. doi:10.3346/jkms.2020.35.e250. PMID: 32700483.